Vitaspring Biomedical
VSBC · OTC
$0.0318+$0.0318 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
VSBC profitability and balance sheet ratios
EPS -$0.0004 in Apr 2026.
| Period | EPS |
|---|---|
| Oct 2022 | -$0.0007 |
| Apr 2024 | -$0.001 |
| Jul 2024 | -$0.0011 |
| Oct 2024 | -$0.0009 |
| Jan 2025 | -$0.0007 |
| Oct 2025 | -$0.0007 |
| Jan 2026 | -$0.0004 |
| Apr 2026 | -$0.0004 |
Income statement
No financial statements are reported for Vitaspring Biomedical.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|
| Total assets | $0.0M | $0.0M | $0.0M |
| Total liabilities | $4.4M | $4.4M | $4.5M |
| Shareholder equity | −$4.3M | −$4.4M | −$4.5M |
| Cash and short-term investments | $0.0M | $0.0M | $0.0M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.